Anti-viral development

Anti-viral development

Existing anti-virals and new drugs in the pipeline, traditional viral suppressive therapies, strategies and industrial resources available to reduce the price of production and distribution -- these factors come together here with clinical trials and academic research to speed anti-viral solutions.


Relaxation of FDA guidelines for human trial testing

Promotion of common sense baseline viral defense

Back to community

This content is created by the open source Your Priorities citizen engagement platform designed by the non profit Citizens Foundation

Your Priorities on GitHub

Check out the Citizens Foundation website for more information